Related Experiment Videos
Pharmacotherapy in stroke rehabilitation
Anna Członkowska1, Marcin Leśniak
1Institute of Psychiatry and Neurology, 2nd Dept of Neurology, 9 Sobieskiego Str., 02-957 Warsaw, Poland. czlonkow@ipin.edu.pl
Expert Opinion on Pharmacotherapy
|May 26, 2009
Summary
Current stroke recovery medications lack proven effectiveness and may hinder neuroplasticity. Future research should focus on agents like growth factors and dopaminergic drugs to improve rehabilitation outcomes.
Area of Science:
- Neuroscience
- Pharmacology
- Rehabilitation Medicine
Background:
- Pharmacotherapy is standard post-stroke care for preventing complications and aiding recovery.
- Concerns exist regarding potential negative impacts of certain drugs on neuroplasticity.
Purpose of the Study:
- To review current pharmacologic agents used to promote motor and cognitive recovery after stroke.
- To evaluate the efficacy, safety, and dosing of these agents.
Main Methods:
- Comprehensive literature review.
- Analysis of drug properties, efficacy, safety, and dosing data.
Main Results:
- Insufficient evidence supports pharmacotherapy for significantly improved rehabilitation outcomes.
- Some agents may impair functional reorganization and slow recovery.
- Noradrenergic agents, dopaminergic agents, and growth factors show promise for future research.
Conclusions:
- No current drug is definitively proven to enhance post-stroke recovery.
- Further randomized clinical trials are needed for promising agents.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...